The Management of Psychiatric Disorders During and After Pregnancy-View Presentation

Video Transcription

Video Summary

Dr. Jennifer L. Payne, a reproductive psychiatrist, gave a presentation on the management of psychiatric disorders during and after pregnancy. She highlighted the importance of treating psychiatric illness during the perinatal period, as untreated depression can lead to poor outcomes for both the mother and the baby. Dr. Payne discussed a general approach to designing a treatment strategy for pregnancy and lactation, emphasizing the need to balance the risks of medication exposure with the risks of untreated psychiatric illness. She also provided an overview of the safety data for various psychiatric medications during pregnancy, and highlighted the importance of conducting well-controlled studies to determine the true risks and benefits. Additionally, Dr. Payne discussed two new FDA-approved medications for postpartum depression, brixanolone and xeranolone, highlighting their rapid efficacy and sustained response. She emphasized that every case is different and decisions should be made on an individual basis, taking into account factors such as medication history, severity of illness, and response to treatment. Overall, Dr. Payne's presentation highlighted the importance of comprehensive care and individualized treatment plans for pregnant and postpartum women with psychiatric disorders.

Keywords

psychiatric disorders

pregnancy

perinatal period

depression

treatment strategy

medication exposure

safety data

postpartum depression

FDA-approved medications

individualized treatment plans